Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase 1/2 Study of Pralatrexate in Previously-treated Advanced or Metastatic Breast Cancer
2008-006425-14Phase 2Active
- Sponsor
- Allos Therapeutics
- Start
- Apr 2009
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules, Nucleic Acid-Directed Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 2, single-arm trial of pralatrexate in breast cancer, sponsored by Allos Therapeutics. Primary endpoints: Phase 1 objectives and Phase 2 objectives. Started Apr 2009; status: active.
02
Drugs
pralatrexate
03
Conditions
breast cancer
Beyond the preview
Go deeper on 2008-006425-14.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2008-006425-14.